The impact of beta-blockers on mortality in stable angina: A meta-analysis

Scottish Medical Journal

Volumn 57, Issue 2, 2012, Pages 69-75

  Huang, H L ^a   Fox, K A A ^b  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Beta blockers; Cardiovascular mortality; Stable angina

Indexed keywords

ANTIANGINA PECTORIS AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; NITRIC ACID DERIVATIVE; PLACEBO;

ARTICLE; CARDIOSELECTIVITY; CARDIOVASCULAR MORTALITY; CONTROLLED STUDY; DRUG RESPONSE; HUMAN; META ANALYSIS; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; STABLE ANGINA PECTORIS; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

ANGINA, STABLE; ANTIHYPERTENSIVE AGENTS; CALCIUM CHANNEL BLOCKERS; FEMALE; HUMANS; MALE; MYOCARDIAL INFARCTION; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84860563390     PISSN: 00369330     EISSN: None     Source Type: Journal    
DOI: 10.1258/smj.2011.011274     Document Type: Article

References (19)

1. The SIGN Guideline Development Group. Management of Stable Angina. Scottish Intercollegiate Guidelines Network (SIGN). Publication No: 96. See http://www.sign.ac.uk/pdf/sign96.pdf (last checked 1 December 2011)
2. Riccioni G. Focus on Ivabradine: a new heart rate-controlling drug. Expert Rev Cardiovasc Ther 2009;7:107-13
3. Salpeter S, Ormiston T, Salpeter E. Cardioselective beta-blockers for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2002;(2):CD003566
4. Karlsson J, Lind L, Hallberg P, et al. Beta1-adrenergic receptor gene polymorphisms and response to beta1-adrenergic receptor blockade in patients with essential hypertension. Clin Cardiol 2004;27:347-50
5. Heidenreich PA, McDonald KM, Hastie T, et al. Meta-analysis of trials comparing beta blockers, calcium antagonists, and nitrates for stable angina. JAMA 1999;281:1927-36
6. Heidenreich PA, McDonald KM, Hastie T, et al. An Evaluation of Beta Blockers, Calcium Antagonists, Nitrates, and Alternative Therapies for Stable Angina. Evidence Report/Technology Assessment No. 10. Rockville, MD: AHRQ, 1999. See http://www.ncbi.nlm.nih.gov/books/bv.fcgi?rid=hstat1.chapter.14350 (last checked 1 December 2011)
7. Sculpher MJ, Petticrew M, Kelland JL, Elliott RA, Holdright DR, Buxton MJ. Resource allocation for chronic stable angina: a systematic review of the effectiveness,costs and cost-effectiveness of alternative interventions. Health Technol Assess 1998;2:i-iv,1-176
8. b-Blocker Heart Attack Trial Research Group. A randomized trial of propranolol in patients with acute myocardial infarction. I. mortality results. JAMA 1982;247:1707-14
9. Boissel JP, Furberg CD, Friedman LM, et al. The beta-blocker pooling project (BBPP): subgroup findings from randomized trials in post infarction patients. Eur Heart J 1988;9:8-16
10. Hippisley-Cox J, Coupland C. Effect of combinations of drugs on all cause mortality in patients with ischaemic heart disease: nested case-control analysis. BMJ 2005;330:1059-63
11. Shibata MC, Flather MD, Wang D. Systematic review of the impact of beta blockers on mortality and hospital admissions in heart failure. Eur J Heart Fail 2001;3:351-57
12. Hernandez AF, Hammill BG, O'Connor CM, et al. Clinical effectiveness of beta-blockers in heart failure: findings from the OPTIMIZE-HF (Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure) registry. J Am Coll Cardiol 2009;53:184-92
13. Leizorovicz A, Lechat P, Cucherat M, et al. Bisoprolol for the treatment of chronic heart failure: a meta-analysis on individual data of two placebo-controlled studies-CIBIS and CIBIS II. Cardiac Insufficiency Bisoprolol Study. Am Heart J 2002;143:301-7
14. Packer M, Fowler MB, Roecker EB, et al. Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study. Circulation 2002; 106:2194-9
15. Hjalmarson A, Goldstein S, Fagerberg B, et al. Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group. JAMA 2000;283: 1295-302
16. Dong BR, Wu T, Yue J, Liu GJ, Defen S. Beta-blockers for stable angina (Protocol). Cochrane Database Syst Rev 2005;(1):CD005152
17. Yusuf S, Peto R, Lewis J, et al. Beta blockade during and after myocardial infraction: an overview of the randomized trials. Prog Cardiovasc Dis 1985;27:335-71
18. Peto R, Pike MC, Armitage P, et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer 1977;35:1-39
19. The Cochrane Collaboration. Review Manager (RevMan) Version 5.0 for Windows [Computer program]. Copenhagen, Denmark: The Nordic Cochrane Centre, 2008